
Formulary Search
You are here : Home > Formulary Search
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Search Results : Nausea and vomiting (chemotherapy induced) (Metoclopramide hydrochloride - Nausea and vomiting (chemotherapy induced))
Records returned : 20 (on 29 May 2025 at 13:05:09).
Return to search results for ' Nausea and vomiting (chemotherapy induced) '.
Show Icon and Status Keys Hide Icon and Status Keys
Icon Key
NFD1
Non formulary
NFD2
Not assessed for formulary status. Apply to APC / DTC before use.
CD
Controlled drug. Prescribing and/or storage requirements may apply
R
Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place
Un
Off-label use. Not licensed for this indication.
NHSE
Treatment commissioned by NHS England
CDF
Cancer Drugs Fund
ICB
Treatment commissioned by the ICB
Link to the NICE website

Low carbon device
Status Key
Red
Specialist ONLY drugs - treatment initiated and continued by specialist clinicians
Amber
Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement
Green
GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.
Green (see narrative)
GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.
Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.
Non Formulary
Not recommended for use in any health setting across the Surrey Heartlands Integrated Care System
Blue
Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.
See narrative
See narrative - may be applied in instances where a traffic light status has not yet been agreed but an entry to the formulary has been made to clarify interim arrangements.
Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Indication :
Status :
Blue
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Important
On request from the specialist / Cancer Centre
Formulary Status :
Links :
Indication :
Status :
Blue
Formulations :
- Tablets
Restrictions / Comments:
Important
On request from the specialist / Cancer Centre.
Formulary Status :
Links :
Indication :
Status :
Red
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Blue
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Important
On request from the specialist / Cancer Centre
Formulary Status :
Links :
Indication :
Status :
Red
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Blue
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Important
Off-label use. On request from the specialist / Cancer Centre
Formulary Status :
Links :
SPC
Un
Indication :
Status :
Blue
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Important
Oral solution reserved for use when tablets are not suitable.
On request from the specialist / Cancer Centre
Formulary Status :
Links :
Indication :
Status :
Blue
Formulations :
- Oro-dispersible
- Orodispersible films
Restrictions / Comments:
Important
Orodispersible preparations reserved for use when ordinary tablets are not suitable.
On request from the specialist / Cancer Centre
Formulary Status :
Links :
Indication :
Status :
Red
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Red
Formulations :
- Capsules
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Red
Formulations :
- Intravenous infusion
Restrictions / Comments:
Important
RSCH Oncology Team only
Formulary Status :
Links :
Indication :
Status :
Red
Formulations :
- Injection
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Red
Formulations :
- Tablets
Restrictions / Comments:
Important
6mg or 6.25mg tablets for chemo-related nausea and vomiting.
ASPH restricted use - 6mg tablets for paediatric oncology only
Formulary Status :
Links :
Indication :
Status :
Red
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Red
Formulations :
- Oro-dispersible
- Tablets
Restrictions / Comments:
Important
Off-label use.
Formulary Status :
Links :
SPC
Un
Indication :
Status :
Red
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Non Formulary
Formulations :
- Injection
- Patches
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Non Formulary
Formulations :
- Capsules
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Non Formulary
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
SPC
NFD1